$7.8bn
$XXX.Xm
42,084
200
$X.Xbn
US fertility clinics have recently seen significant changes driven by evolving patient needs and technological advancements. The industry has been adapting to higher demand for personalized treatments and the rise of telemedicine, all while managing the effects of fluctuating insurance coverage and varying success rates. These factors have shaped the recent performance of fertility clinics, highlighting both opportunities and challenges as they navigate this dynamic landscape. Industry-wide revenue grew at an average annualized 5.5% over the past five years and are expected to total $9.9 billion in 2024, when revenue will jump by an estimated 1.5%.
Industry revenue has grown at a CAGR of 0.7 % over the past five years, to reach an estimated $7.8bn in 2024.
Market size is projected to grow over the next five years.
Company | Market Share (%)
2024 | Revenue ($m)
2024 | Profit ($m)
2024 | Profit Margin (%)
2024 |
---|---|---|---|---|
Integramed America Inc. | 664.6 | 46.0 | 6.9 | |
Planned Parenthood Federation of America Inc. | 178.8 | 8.5 | 4.8 |
To view the market share and analysis for all 2 top companies in this industry, view purchase options.
Industry revenue is measured across several distinct product and services lines, including Fertility testing and consultations, Assisted reproductive technology and artificial insemination and Fertility medications. Fertility testing and consultations is the largest segment of the Fertility Clinics in the US.
Advances in assisted reproductive technology encourage patients to bear the high costs
This industry includes medical facilities that offer treatments to aid individuals in conceiving children. These facilities offer diagnosis, medications, intrauterine insemination, in vitro fertilization and other assisted reproductive technology methods.
Purchase this report to view all 2 major companies in this industry.
NAICS 62141 - Fertility Clinics in the US
Get an indication of the industry's health through historical, current and forward-looking trends in the performance indicators that make or break businesses.
Rising infertility rates are bringing fertility clinics to the forefront of family planning. More couples decide to marry or start a family later in life, leading them to fer...
Learn about an industry's products and services, markets and trends in international trade.
Fertility clinics receive the most payments for performing in vitro fertilization procedures. Patients visit clinics for several fertility services, but IVF is where spending...
Discover where business activity is most concentrated in an industry and the factors driving these trends to find opportunities and conduct regional benchmarking.
California has the most fertility clinics in the US. The state’s access to tech hubs and progressive insurance policies incentivize clinics to practice here.
Get data and insights on what's driving competition in an industry and the challenges industry operators and new entrants may face, with analysis built around Porter's Five Forces framework.
Potential patients can easily compare success rates between fertility clinics. Patients struggling with fertility want to visit clinics with established histories of successf...
Learn about the performance of the top companies in the industry.
Delivery of fertility treatment is fragmented. Most fertility clinics are standalone providers delivering care to patients on a local or regional basis, keeping any one clini...
Understand the demographic, economic and regulatory factors that shape how businesses in an industry perform.
Assisted reproductive treatment is one of the most highly regulated medical services in the US. Fertility clinics navigate an increasingly complex framework of federal, state...
View average costs for industry operators and compare financial data against an industry's financial benchmarks over time.
Success rates determine a clinic's profitability. Patients will pay the steep costs of fertility treatment at clinics where chances of success are highest.
Including values and annual change:
IBISWorld has been a leading provider of trusted industry research for over 50 years to the most successful companies worldwide. With offices in Australia, the United States, the United Kingdom, Germany and China, we are proud to have local teams of analysts that conduct research, data analysis and forecasting to produce data-driven industry reports.
Our analysts start with official, verified and publicly available sources of data to build the most accurate picture of each industry. Analysts then leverage their expertise and knowledge of the local markets to synthesize trends into digestible content for IBISWorld readers. Finally, each report is reviewed by one of IBISWorld’s editors, who provide quality assurance to ensure accuracy and readability.
IBISWorld relies on human-verified data and human-written analysis to compile each standard industry report. We do not use generative AI tools to write insights, although members can choose to leverage AI-based tools within the platform to generate additional analysis formats.
Each industry report incorporates data and research from government databases, industry-specific sources, industry contacts, and our own proprietary database of statistics and analysis to provide balanced, independent and accurate insights.
Key data sources in the US include:
Analysts also use industry specific sources to complement catch-all sources, although their perspective may focus on a particular organization or representative body, rather than a clear overview of all industry operations. However, when balanced against other perspectives, industry-specific sources provide insights into industry trends.
These sources include:
Finally, IBISWorld’s global data scientists maintain a proprietary database of macroeconomic and demand drivers, which our analysts use to help inform industry data and trends. They also maintain a database of statistics and analysis on thousands of industries, which has been built over our more than 50-year history and offers comprehensive insights into long-term trends.
IBISWorld’s analysts and data scientists use the sources above to create forecasts for our proprietary datasets and industry statistics. Depending on the dataset, they may use regression analysis, multivariate analysis, time-series analysis or exponential smoothing techniques to project future data for the industry or driver. Additionally, analysts will leverage their local knowledge of industry operating and regulatory conditions to impart their best judgment on the forecast model.
IBISWorld prides itself on being a trusted, independent source of data, with over 50 years of experience building and maintaining rich datasets and forecasting tools. We are proud to be the keystone source of industry information for thousands of companies across the world.
Learn more about our methodology and data sourcing on the Help Center.
Unlock comprehensive answers and precise data upon purchase. View purchase options.
The market size of the Fertility Clinics in the US industry in United States is $7.8bn in 2024.
There are 200 businesses in the Fertility Clinics in the US industry in United States, which has declined at a CAGR of 0.0 % between 2019 and 2024.
The market size of the Fertility Clinics in the US industry in United States has been growing at a CAGR of 0.7 % between 2019 and 2024.
Over the next five years, the Fertility Clinics in the US industry in United States is expected to grow.
The biggest companies operating in the Fertility Clinics market in United States are Integramed America Inc. and Planned Parenthood Federation of America Inc.
Infertility evaluations and Egg freezing are part of the Fertility Clinics in the US industry.
The company holding the most market share in United States is Integramed America Inc..
The level of competition is moderate and steady in the Fertility Clinics in the US industry in United States.